Navigating the Current Landscape: An Update on the USDA and FDA
In February, after the USDA delayed the DEA testing requirement for hemp, the industry breathed a short sigh of relief. But the crop’s new regulator says to expect little lenience in the long run, and that the industry’s wish to raise THC limits on hemp is a total no-go without congressional interference. Meanwhile, a global pandemic has impacted the economy and the FDA looms to regulate how hemp extracts such as CBD can be sold. It is a confusing time for hemp operators – but successful hemp entrepreneurs can thrive amid the uncertainty and make slow-moving changes work for them.
In this session, you will learn:
- How to navigate USDA rules in 2020 – especially when they clash with what state regulators require.
- The FDA’s current approach to cannabinoids and what it means for your business.
- Has the COVID-19 pandemic impacted how quickly the FDA plans to move forward with CBD regulations
- Tips and tricks for working with government agencies who can shut your business down or allow it to flourish.